Skip to main content

Market Overview

Morning Market Losers


Supercom Ltd (NASDAQ: SPCB) shares tumbled 32.86 percent to $5.17. Supercom expects Q3 revenue of $5.5 million to $6.1 million and FY revenue to exceed $30 million. The company also announced a contract of $8 million.

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares dipped 23.03 percent to $0.785 after gaining 47.83 percent on Friday. Martin Shkreli in YouTube live stream on Sunday said that Cyclacel Pharmaceuticals stock is worthless.

AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) shares slipped 15.73 percent to $9.32. Martin Shkreli said that AEterna Zentaris is worthless.

Macrocure Ltd (NASDAQ: MCUR) dropped 10.66 percent to $2.18 after jumping 25.77 percent on Friday. Martin Shkreli said that Macrocure is worthless.

KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares declined 8.73 percent to $31.79 after gaining 30.79 percent on Friday.

Prestige Brands Holdings, Inc. (NYSE: PBH) shares slipped 8.34 percent to $49.67. Jefferies downgraded Prestige Brand Holdings from Hold to Underperform and raised the price target to $44.00.

China Housing & Land Development, Inc. (NASDAQ: CHLN) shares dropped 7.91 percent to $4.14 after the company reported that it will hold a special meeting of stockholders on December 30, 2015 to vote on its "going private" transaction.

Lululemon Athletica inc. (NASDAQ: LULU) shares fell 6.57 percent to $49.05. FBR Capital downgraded Lululemon Athletica from Market Perform to Underperform and lowered the price target from $55.00 to $42.00.


Related Articles (CYCC + SPCB)

View Comments and Join the Discussion!

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at